Inhibitory Effect of Tanshinone IIA Nanomicelles on Tumor Growth and Angiogenesis in Mice with Cervical Carcinoma Transplantation

被引:1
作者
Hu, Ruihua [1 ]
Chen, Aimin [2 ]
机构
[1] Anhui Univ Technol, Affiliated Hosp 1, Tradit Chinese Med Dept, Huainan 232007, Anhui, Peoples R China
[2] Anhui Univ Technol, Affiliated Hosp 1, Dept Pharm, Huainan 232007, Anhui, Peoples R China
关键词
KEYWORDS; Tanshinone IIA; Polyglutamic Acid; Nanometer Micelle; Cervical Cancer; Angiogenesis; carriers include liposomes; nanoparticles; nanogels; solid; HYPOCRELLIN B; DOCETAXEL; ACID; NANOPARTICLES; GLYCOL; CELLS;
D O I
10.1166/sam.2023.4445
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
In recent years, traditional Chinese medicine (TCM), represented by tanshinone (Tas) and ganoderan polysac-charides, has attracted the attention of many scientists due to its mild effect of inhibiting tumors. In this research, poly-gamma-glutamic acid (y-PGA) was degraded into small molecule y-PGA fragments by high-temperature acidolysis, and L-phenylalanine ethylester (L-PAE) was combined with small molecule y-PGA fragments to gen-erate y-PGA-LA by dehydration condensation. The material was mixed with fat-soluble Tas IIA to form PL-Tas IIA nanomicelles (NMs). In addition to physical characterization, the in vitro biological activity of the material was detected to establish a tumor-bearing nude mouse model, which was inoculated with cervical cancer HeLa cells. The nude mouse models were grouped, and the effect of NMs on the growth of transplanted tumors was observed by intraperitoneal injection. The results revealed that the nanoparticle size was approximately 139.6 +/- 3.8 nm, and it had a good EPR effect, whicwas conducive to passive targeted therapy of tumors. IP: 203.8.109.20 On: Th u, 11 May 2023 08:14:14 The polydispersity coefficient and zeta potential were 0.138 +/- 0.005 and 33.6 +/- 1.6 mV, respectively. The NM Copyright: American Scientific Publishers was cocultured with the cells under various concentration conditions, and the cell survival rate was more than Delivered by Ingenta 85%. The tumor cell uptake performance of the NM was ideal, and the cell uptake ratio reached 71.62% at 60 min, as determined by flow cytometry. An in vivo tumor test demonstrated that PL-Tas IIA had a favorite tumor inhibition effect. The tumor-bearing nude mouse model showed that the prepared NMs can inhibit tumor growth, induce angiogenesis of xenografts, and further induce tumor cell apoptosis, further verifying that the prepared NMs can inhibit cervical cancer tumor growth.
引用
收藏
页码:319 / 329
页数:11
相关论文
共 32 条
  • [1] p53 and Tumor Suppression: It Takes a Network
    Boutelle, Anthony M.
    Attardi, Laura D.
    [J]. TRENDS IN CELL BIOLOGY, 2021, 31 (04) : 298 - 310
  • [2] RGD-modified pH-sensitive liposomes for docetaxel tumor targeting
    Chang, Minglu
    Lu, Shanshan
    Zhang, Fang
    Zuo, Tiantian
    Guan, Yuanyuan
    Wei, Ting
    Shao, Wei
    Lin, Guimei
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2015, 129 : 175 - 182
  • [3] Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and in vitro insights
    Elebeedy, Dalia
    Elkhatib, Walid F.
    Kandeil, Ahmed
    Ghanem, Aml
    Kutkat, Omnia
    Alnajjar, Radwan
    Saleh, Marwa A.
    Maksoud, Ahmed I. Abd El
    Badawy, Ingy
    Al-Karmalawy, Ahmed A.
    [J]. RSC ADVANCES, 2021, 11 (47) : 29267 - 29286
  • [4] The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells
    Gruber, Martina
    Handle, Florian
    Culig, Zoran
    [J]. PROSTATE, 2020, 80 (03) : 267 - 273
  • [5] Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases
    Guo, Rui
    Li, Lan
    Su, Jing
    Li, Sheng
    Duncan, Sophia Esi
    Liu, Zhihao
    Fan, Guanwei
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 4735 - 4748
  • [6] Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy
    Han, Huiying
    Jain, Atul D.
    Truica, Mihai I.
    Izquierdo-Ferrer, Javier
    Anker, Jonathan F.
    Lysy, Barbara
    Sagar, Vinay
    Luan, Yi
    Chalmers, Zachary R.
    Unno, Kenji
    Mok, Hanlin
    Vatapalli, Rajita
    Yoo, Young A.
    Rodriguez, Yara
    Kandela, Irawati
    Parker, J. Brandon
    Chakravarti, Debabrata
    Mishra, Rama K.
    Schiltz, Gary E.
    Abdulkadir, Sarki A.
    [J]. CANCER CELL, 2019, 36 (05) : 483 - +
  • [7] Tanshinone IIA protects human coronary artery endothelial cells from ferroptosis by activating the NRF2 pathway
    He, Lina
    Liu, Ying-Yi
    Wang, Kun
    Li, Chengxi
    Zhang, Weibin
    Li, Zhen-Zhen
    Huang, Xian-Zhang
    Xiong, Yujuan
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 575 : 1 - 7
  • [8] Cytoprotective role of nitric oxide in HepG2 cell apoptosis induced by hypocrellin B photodynamic treatment
    Ji, Yuan Yuan
    Ma, Yan Jun
    Wang, Jian Wen
    [J]. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2016, 163 : 366 - 373
  • [9] Preclinical Activity of HER2-Selective Tyrosine Kinase Inhibitor Tucatinib as a Single Agent or in Combination with Trastuzumab or Docetaxel in Solid Tumor Models
    Kulukian, Anita
    Lee, Patrice
    Taylor, Janelle
    Rosler, Robert
    de Vries, Peter
    Watson, Daniel
    Forero-Torres, Andres
    Peterson, Scott
    [J]. MOLECULAR CANCER THERAPEUTICS, 2020, 19 (04) : 976 - 987
  • [10] Tumor microenvironment-responsive docetaxel-loaded micelle combats metastatic breast cancer
    Lang, Tianqun
    Dong, Xinyue
    Zheng, Zhong
    Liu, Yiran
    Wang, Guanru
    Yin, Qi
    Li, Yaping
    [J]. SCIENCE BULLETIN, 2019, 64 (02) : 91 - 100